Serina Therapeutics, Inc. (NYSEAMERICAN:SER – Get Free Report) shares were up 6% during trading on Wednesday . The stock traded as high as $1.8493 and last traded at $1.77. Approximately 88,947 shares changed hands during trading, a decline of 98% from the average daily volume of 3,986,063 shares. The stock had previously closed at $1.67.
Serina Therapeutics Stock Up 6.0%
The firm has a market cap of $19.10 million, a price-to-earnings ratio of -0.95 and a beta of 1.20.
Serina Therapeutics Company Profile
Serina Therapeutics, Inc, a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson’s disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson’s disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc was founded in 2006 and is based in Huntsville, Alabama.
Featured Stories
- Five stocks we like better than Serina Therapeutics
- REVEALED: Something Big Happening Behind White House Doors
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Elon Musk: This Could Turn $100 into $100,000
- Read this or regret it forever
- The Next Commodity Crunch (bigger than oil?)
Receive News & Ratings for Serina Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Serina Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
